title: Sirolimus-induced inflammatory lymphoedema of the breast resolved after switching to cyclosporine.
authors.affiliation: Department of Dermatology, CHRU de Tours, FR-37044 Tours, France.
authors.forename: Valérie
authors.initials: V
authors.lastname: Tauveron
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Bourdu
authors.forename: Christelle
authors.initials: C
authors.lastname: Barbet
authors.forename: Anne
authors.initials: A
authors.lastname: de Muret
authors.forename: Martine
authors.initials: M
authors.lastname: Burgot
authors.forename: Franck
authors.initials: F
authors.lastname: Desmidt
authors.forename: Loïc
authors.initials: L
authors.lastname: Vaillant
authors.forename: Laurent
authors.initials: L
authors.lastname: Machet
mesh_terms: D001941:Breast Diseases / Q000139:chemically induced* / Q000175:diagnosis; D016572:Cyclosporine / Q000627:therapeutic use*; D057915:Drug Substitution; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D008209:Lymphedema / Q000139:chemically induced* / Q000175:diagnosis; D008875:Middle Aged; D012307:Risk Factors; D020123:Sirolimus / Q000009:adverse effects*; D016217:Ultrasonography, Mammary
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus